We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$75.5B
AUM Growth
+$6.03B
Cap. Flow
+$664M
Cap. Flow %
0.88%
Top 10 Hldgs %
13.76%
Holding
1,022
New
110
Increased
407
Reduced
342
Closed
107

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$440M
2
QCOM icon
Qualcomm
QCOM
+$412M
3
BIDU icon
Baidu
BIDU
+$207M
4
UPS icon
United Parcel Service
UPS
+$185M
5
KO icon
Coca-Cola
KO
+$168M

Sector Composition

Rank Sector Weight
1 Energy 16.71%
2 Financials 13.65%
3 Communication Services 11.71%
4 Technology 11.31%
5 Healthcare 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
276
Capital One
COF
$124B
$64M 0.08%
930,377
+9,996
+1% +$673K
FTNT icon
277
Fortinet
FTNT
$112B
$63.4M 0.08%
15,645,380
-112,485
-0.7% -$455K
USAC icon
278
USA Compression Partners
USAC
$3.82B
$63.4M 0.08%
2,660,871
+909,285
+52% +$22.2M
CPHD
279
DELISTED
Cepheid Inc
CPHD
$62.5M 0.08%
1,600,000
-253,726
-14% -$9.19M
EG icon
280
Everest Group
EG
$15.2B
$62.3M 0.08%
428,625
+970
+0.2% +$131K
OXY icon
281
Occidental Petroleum
OXY
$57B
$62M 0.08%
692,033
-3,484
-0.5% -$299K
LHO
282
DELISTED
LaSalle Hotel Properties
LHO
$61.7M 0.08%
2,164,602
+261,640
+14% +$7.1M
EL icon
283
Estee Lauder
EL
$29B
$61.6M 0.08%
881,780
-1,374,300
-61% -$93.1M
SGEN
284
DELISTED
Seagen Inc. Common Stock
SGEN
$61.4M 0.08%
1,400,000
-100,000
-7% -$4.16M
NVO
285
Novo Nordisk
NVO
$216B
$61.1M 0.08%
3,610,740
-1,955,100
-35% -$32.9M
NGL icon
286
NGL Energy Partners
NGL
$1.94B
$61.1M 0.08%
1,981,029
+1,431,395
+260% +$43.1M
DXCM icon
287
DexCom
DXCM
$27.6B
$60.3M 0.08%
8,549,140
-1,154,916
-12% -$7.32M
NWL icon
288
Newell Brands
NWL
$2.16B
$60.2M 0.08%
2,190,113
+818,473
+60% +$21.8M
GWW icon
289
W.W. Grainger
GWW
$65.3B
$60.1M 0.08%
229,550
-200,740
-47% -$52.2M
USB icon
290
US Bancorp
USB
$99.6B
$59.5M 0.08%
1,625,748
+432,170
+36% +$16M
AME icon
291
Ametek
AME
$55.5B
$59.4M 0.08%
1,290,824
+22,850
+2% +$1.03M
SPLK
292
DELISTED
Splunk Inc
SPLK
$59M 0.08%
982,671
+29,655
+3% +$1.58M
BA icon
293
Boeing
BA
$165B
$58.8M 0.08%
500,000
HTS
294
DELISTED
HATTERAS FINANCIAL CORP
HTS
$58.1M 0.08%
3,106,936
-1,278
-0% -$25.7K
PLD icon
295
Prologis
PLD
$138B
$57.8M 0.08%
1,535,300
+447,280
+41% +$16.9M
AZPN
296
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$57.7M 0.08%
1,669,350
-27,330
-2% -$944K
KDP icon
297
Keurig Dr Pepper
KDP
$40.4B
$57.6M 0.08%
1,286,008
-2,682,816
-68% -$123M
GD icon
298
General Dynamics
GD
$105B
$57.3M 0.08%
654,200
CHRD icon
299
Chord Energy
CHRD
$7.79B
$57.3M 0.08%
1,165,350
-19,920
-2% -$837K
RWT
300
Redwood Trust
RWT
$616M
$57.2M 0.08%
2,903,015
+436,551
+18% +$7.78M

Similar funds

OppenheimerFunds's Q3 2013 Portfolio in Review

As of Q3 2013, OppenheimerFunds held 1,022 positions worth $75.5B, up 8.7% from $69.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

OppenheimerFunds's Q3 2013 filing shows 110 new, 407 increased, 342 reduced and 107 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M. The largest sale was Allergan plc, an estimated $440M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.

  • OppenheimerFunds's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M.
  • OppenheimerFunds added most to Televisa in Q3 2013, an estimated $308M increase.
  • OppenheimerFunds's biggest Q3 2013 reduction was Allergan plc, cutting an estimated $440M.
  • OppenheimerFunds fully exited BROADCOM CORP CL-A in Q3 2013, selling an estimated $164M.
  • OppenheimerFunds's ten largest holdings make up 14% of its $75.5B portfolio in Q3 2013.
  • OppenheimerFunds opened 110 new positions and closed 107 in Q3 2013.
  • OppenheimerFunds's portfolio value rose 8.7% quarter-over-quarter to $75.5B.

Based on OppenheimerFunds's 13F filing for Q3 2013, filed 14 Nov 2013.